Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1858 ARTÍCULOS , VIENDO DEL 481 AL 495

Generation of an induced pluripotent stem cell line (SIAISi003-A) from a 79-year-old patient with Alzheimer's disease having APOE3/4 genetic background

Dai Q, Zhang W, Guo J, Di W, Zhao J, Zhang B, Wang Y.

Stem Cell Res. 2020 Oct;48:101949. doi: 10.1016/j.scr.2020.101949. Epub 2020 Aug 5.

Potential Role of Extracellular CIRP in Alcohol-Induced Alzheimer's Disease

Sharma A, Brenner M, Wang P.

Mol Neurobiol. 2020 Dec;57(12):5000-5010. doi: 10.1007/s12035-020-02075-1. Epub 2020 Aug 21.

The role of synaptic microRNAs in Alzheimer's disease

Kumar S, Reddy PH.

Biochim Biophys Acta Mol Basis Dis. 2020 Dec 1;1866(12):165937. doi: 10.1016/j.bbadis.2020.165937. Epub 2020 Aug 20.

Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment

Liu S, Gao J, Zhu M, Liu K, Zhang HL.

Mol Neurobiol. 2020 Dec;57(12):5026-5043. doi: 10.1007/s12035-020-02073-3. Epub 2020 Aug 23.

Myeloproliferative blood cancers as a human neuroinflammation model for development of Alzheimer's disease: evidences and perspectives

Hasselbalch HC, Skov V, Kjær L, Sørensen TL, Ellervik C, Wienecke T.

J Neuroinflammation. 2020 Aug 23;17(1):248. doi: 10.1186/s12974-020-01877-3.

In Vivo TSPO Signal and Neuroinflammation in Alzheimer's Disease

Tournier BB, Tsartsalis S, Ceyzériat K, Garibotto V, Millet P.

Cells. 2020 Aug 21;9(9):1941. doi: 10.3390/cells9091941.

The Crosstalk Between Pathological Tau Phosphorylation and Mitochondrial Dysfunction as a Key to Understanding and Treating Alzheimer's Disease

Guha S, Johnson GVW, Nehrke K.

Mol Neurobiol. 2020 Dec;57(12):5103-5120. doi: 10.1007/s12035-020-02084-0. Epub 2020 Aug 26.

ATP synthase and Alzheimer's disease: putting a spin on the mitochondrial hypothesis

Ebanks B, Ingram TL, Chakrabarti L.

Aging (Albany NY). 2020 Aug 27;12(16):16647-16662. doi: 10.18632/aging.103867. Epub 2020 Aug 27.

Extra-cranial factors in the development of Alzheimer's disease

Eiser AR, Fulop T.

Brain Res. 2020 Dec 1;1748:147076. doi: 10.1016/j.brainres.2020.147076. Epub 2020 Aug 24.

A role for sodium glucose cotransporter 2 inhibitors (SGLT2is) in the treatment of Alzheimer's disease?

Esterline R, Oscarsson J, Burns J.

Int Rev Neurobiol. 2020;155:113-140. doi: 10.1016/bs.irn.2020.03.018. Epub 2020 Aug 11.

Harnessing neurogenesis in the adult brain-A role in type 2 diabetes mellitus and Alzheimer's disease

Lazarov O, Minshall RD, Bonini MG.

Int Rev Neurobiol. 2020;155:235-269. doi: 10.1016/bs.irn.2020.03.020.

Toll-like receptors in Alzheimer's disease

Momtazmanesh S, Perry G, Rezaei N.

J Neuroimmunol. 2020 Nov 15;348:577362. doi: 10.1016/j.jneuroim.2020.577362. Epub 2020 Aug 19.

Delta-secretase cleavage of Tau mediates its pathology and propagation in Alzheimer's disease

Kang SS, Ahn EH, Ye K.

Exp Mol Med. 2020 Aug;52(8):1275-1287. doi: 10.1038/s12276-020-00494-7. Epub 2020 Aug 28.

Therapeutic potentials of neural stem cells in Alzheimer's disease

Wong RSY, Cheong SK.

Malays J Pathol. 2020 Aug;42(2):157-170.

Unwinding Complexities of Diabetic Alzheimer by Potent Novel Molecules

Gupta S, Nair A, Jhawat V, Mustaq N, Sharma A, Dhanawat M, Khan SA.

Am J Alzheimers Dis Other Demen. 2020 Jan-Dec;35:1533317520937542. doi: 10.1177/1533317520937542.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias